Clinical Trials · NCT00817739
Intermittent Hormonal Therapy With Leuprorelin and Flutamide in the Treatment of Stage D2 or TxNxM1b,c
- Phase
- Phase 2
- Recruitment status
- Completed
- Sponsor
- Takeda
- Enrollment
- 341
- Start date
- Dec 1996
- Locations
- See registry
- Primary endpoint
- Median Overall Survival